Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASIRIVIMAB vs CEDIRANIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CASIRIVIMAB vs CEDIRANIB: Safety Overview

Metric CASIRIVIMAB CEDIRANIB
Total FAERS Reports 500 130
Deaths Reported 24 27
Death Rate 4.8% 20.8%
Hospitalizations 209 71
Average Patient Age 58.9 yrs 61.2 yrs
% Female Patients 52.4% 62.3%